DOCSLIB.ORG

Use of Minerals in Foods

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Use of Minerals in Foods Federal Institute for Risk Assessment Published by A. Domke, R. Großklaus, B. Niemann, H. Przyrembel, K. Richter, E. Schmidt, A. Weißenborn, B. Wörner, R. Ziegenhagen Use of Minerals in Foods Toxicological and nutritional-physiological aspects Part II Imprint BfR Wissenschaft A. Domke, R. Großklaus, B. Niemann, H. Przyrembel, K. Richter, E. Schmidt, A. Weißenborn, B. Wörner, R. Ziegenhagen Use of Minerals in Foods – Toxicological and nutritional-physiological aspects Federal Institute for Risk Assessment Press and Public Relations Office Thielallee 88-92 D-14195 Berlin Berlin 2005 (BfR-Wissenschaft 01/2006) 308 pages, 3 figures, 42 tables € 15 Printed by: Contents and binding BfR-Hausdruckerei Dahlem ISSN 1614-3795 ISBN 3-938163-11-9 BfR-Wissenschaft 3 Contents 1 Preface 11 2 Glossary and Abbreviations 13 3 Introduction 15 3.1 Description of the problem 15 3.2 Principles for the risk assessment of vitamins and minerals including trace elements 16 3.3 Method to derive maximum levels for individual products 17 3.3.1 Structure of the report 17 3.3.2 Principles to derive maximum levels for vitamins and minerals in food supplements and fortified foods 18 3.3.2.1 Theoretical foundations 18 3.3.2.1.1 Derivation of tolerable vitamin and mineral levels for additional intake through food supplements and fortified foods 19 3.3.2.1.2 Derivation of the total tolerable intake of a vitamin or mineral via food supplements or the total intake level for via fortified foods 19 3.3.2.1.3 Derivation of maximum levels for individual food supplements (TLFS) 20 3.3.2.1.4 Derivation of maximum levels for individual fortified foods (TLFF) 20 3.3.2.2 Practical implementation 21 3.4 Tabular overview of the results 21 3.5 References 25 4 Risk Assessment of Sodium 27 4.1 Summary 27 4.2 Nutrient description 28 4.2.1 Characterisation and identification 28 4.2.2 Metabolism, functions, requirements 28 4.2.3 Exposure (dietary and other sources, nutritional status) 31 4.3 Risk characterisation 33 4.3.1 Hazard characterisation (LOAEL, NOAEL) 33 4.3.2 Risks which can be linked in the long-term to high sodium or salt intakes 34 4.3.2.1 Cardiovascular risk factors and mortality 34 4.3.2.2 Carcinoma risk 36 4.3.2.3 Nephrolithiasis risk 36 4.3.2.4 Osteoporosis risk 36 4.3.2.5 Risk of kidney damage 36 4.3.2.6 Burden on water status 36 4.3.3 Deficiency, possible risk groups 37 4.3.3.1 Deficiency 37 4.3.4 Possible risk groups for deficiency 37 4.3.5 Relative excess, possible risk groups 38 4.3.5.1 Relative excess and pathological sodium regulation 38 4.3.6 Possible risk groups in conjunction with increasing supplementation with sodium/salt 39 4.4 Tolerable upper intake level for sodium 39 4.4.1 Derivation of a maximum level for sodium in food supplements 41 4 BfR-Wissenschaft 4.4.1.1 Possible management options 41 4.4.2 Derivation of a maximum level for sodium in fortified foods 42 4.4.2.1 Possible management options 42 4.5 References 47 5 Risk Assessment of Chloride 53 5.1 Summary 53 5.2 Nutrient description 53 5.2.1 Characterisation and identification 53 5.2.2 Metabolism, function, requirements 54 5.2.3 Exposure (dietary and other sources, nutritional status) 55 5.3 Risk characterisation 56 5.3.1 Hazard characterisation (NOAEL, LOAEL) 56 5.3.2 Deficiency, possible risk groups 57 5.3.3 Excessive intake, possible risk groups 57 5.4 Tolerable upper intake level for chloride 58 5.4.1 Derivation of a maximum level for chloride in food supplements and fortified foods 58 5.5 Gaps in knowledge 59 5.6 References 59 6 Risk Assessment of Potassium 61 6.1 Summary 61 6.2 Nutrient description 61 6.2.1 Characterisation and identification 61 6.2.2 Metabolism, function, requirements 62 6.2.3 Exposure (dietary and other sources, nutritional status) 66 6.3 Risk characterisation 68 6.3.1 Hazard characterisation (NOAEL, LOAEL) 68 6.3.2 Deficiency, possible risk groups 71 6.3.2.1 Deficiency 71 6.3.3 Possible risk groups 72 6.3.4 Excessive intake, possible risk groups 72 6.3.4.1 Excessive intake 72 6.3.5 Possible risk groups 73 6.4 Tolerable upper intake level for potassium 74 6.4.1 Derivation of a maximum level (TLNEM) for potassium in food supplements 75 6.4.1.1 Possible management options 75 6.4.2 Derivation of a maximum level (TLFS) for potassium in fortified foods 76 6.5 Gaps in knowledge 78 6.6 References 78 7 Risk Assessment of Calcium 89 7.1 Summary 89 7.2 Nutrient description 89 7.2.1 Characterisation and identification 89 7.2.2 Metabolism, function, requirements 90 7.2.3 Exposure (dietary and other sources, nutritional status) 93 7.3 Risk characterisation 95 BfR-Wissenschaft 5 7.3.1 Hazard characterisation (NOAEL, LOAEL) 95 7.3.2 Deficiency, possible risk groups 99 7.3.3 Excessive intake, possible risk groups 100 7.4 Tolerable upper intake level for calcium 101 7.4.1 Derivation of a maximum level for calcium in food supplements 102 7.4.1.1 Possible management options 102 7.4.2 Derivation of a maximum level for calcium in fortified foods 103 7.4.2.1 Possible management options 103 7.5 Gaps in knowledge 104 7.6 References 105 8 Risk Assessment of Phosphorus 109 8.1 Summary 109 8.2 Nutrient description 109 8.2.1 Characterisation and identification 109 8.2.2 Metabolism, function, requirements 110 8.2.3 Exposure (dietary and other sources, nutritional status) 111 8.3 Risk characterisation 114 8.3.1 Hazard characterisation (NOAEL, LOAEL) 114 8.3.2 Deficiency, possible risk groups 114 8.3.2.1 Deficiency 114 8.3.3 Excessive intake, potential risk groups 115 8.4 Tolerable upper intake level for phosphorus 116 8.4.1 Derivation of a maximum level for phosphorus in food supplements 117 8.4.1.1 Possible management options 117 8.4.2 Derivation of a maximum level for phosphorus in fortified foods 117 8.4.2.1 Possible management options 117 8.5 References 118 9 Risk Assessment of Magnesium 121 9.1 Summary 121 9.2 Nutrient description 121 9.2.1 Characterisation and identification 121 9.2.2 Metabolism, function, requirements 122 9.2.3 Exposure (dietary and other sources, nutritional status) 124 9.3 Risk characterisation 127 9.3.1 Hazard characterisation (NOAEL, LOAEL) 127 9.3.2 Deficiency, possible risk groups 128 9.3.2.1 Deficiency 128 9.3.3 Possible risk groups for deficiency 130 9.3.4 Excessive intake, possible risk groups 130 9.4 Tolerable upper intake level for magnesium 131 9.4.1 Derivation of a maximum level for magnesium in food supplements 131 9.4.1.1 Possible management options 131 9.4.2 Derivation of a maximum level (TLFS) for magnesium in fortified foods 134 9.4.2.1 Possible management options 134 9.5 Gaps in knowledge 136 9.6 References 136 6 BfR-Wissenschaft 10 Risk Assessment of Iron 145 10.1 Summary 145 10.2 Nutrient description 145 10.2.1 Characterisation and identification 145 10.2.2 Metabolism, function, requirements 148 10.2.3 Exposure (dietary and other sources, nutritional status) 157 10.3 Risk characterisation 159 10.3.1 Hazard characterisation (LOAEL, NOAEL) 159 10.3.2 Iron overload and risks linked to high intakes and higher iron stores 160 10.3.2.1 Other adverse effects 166 10.3.3 Deficiency, possible risk groups 166 10.3.3.1 Deficiency 166 10.3.4 Possible risk groups for deficiency 167 10.3.5 Excessive intake, possible risk groups 169 10.3.5.1 Excessive intake 169 10.3.6 Possible risk groups in conjunction with growing iron supplementation 169 10.4 Tolerable upper intake level for iron 169 10.4.1 Derivation of a maximum level for iron in food supplements 171 10.4.1.1 Possible management options 172 10.4.2 Derivation of a maximum level for food in fortified foods 172 10.4.2.1 Possible management options 172 10.5 References 173 11 Risk Assessment of Iodine 189 11.1 Summary 189 11.2 Nutrient description 189 11.2.1 Characterisation and identification 189 11.2.2 Metabolism, function, requirements 190 11.2.3 Exposure (dietary and other sources, nutritional status) 194 11.3 Risk characterisation 198 11.3.1 Hazard characterisation (NOAEL, LOAEL) 198 11.3.2 Deficiency, possible risk groups 199 11.3.2.1 Deficiency 199 11.3.3 Possible risk groups for insufficient intake 201 11.3.4 Excessive intake, possible risk groups 201 11.3.4.1 Excessive intake 201 11.3.5 Possible risk groups 206 11.4 Tolerable upper intake level for iodine 207 11.4.1 Derivation of a maximum level for iodine in food supplements 210 11.4.1.1 Possible management options 210 11.4.2 Derivation of a maximum level for iodine in fortified foods 210 11.4.2.1 Possible management options 211 11.5 Gaps in knowledge 212 11.6 References 212 12 Risk Assessment of Fluoride 227 12.1 Summary 227 12.2 Nutrient description 227 12.2.1 Characterisation and identification 227 BfR-Wissenschaft 7 12.2.2 Metabolism, functions, requirements 228 12.2.3 Exposure (dietary and other sources, nutritional status) 230 12.3 Risk characterisation 232 12.3.1 Hazard characterisation (NOAEL, LOAEL) 232 12.3.2 Deficiency, possible risk groups 233 12.3.3 Excessive intake, possible risk groups 233 12.4 Tolerable upper intake level for fluoride 234 12.4.1 Derivation of a maximum level for fluoride in food supplements 235 12.4.2 Derivation of a maximum level for fluoride in fortified foods 235 12.5 References 236 13 Risk Assessment of Zinc 239 13.1 Summary 239 13.2 Nutrient description 239 13.2.1 Characterisation and identification 239 13.2.2 Metabolism, functions, requirements 240 13.2.3 Exposure (dietary and other sources, nutritional status) 240 13.3 Risk characterisation 241 13.3.1 Hazard characterisation (NOAEL, LOAEL) 241 13.3.2 Deficiency, possible risk groups 242 13.3.3 Excessive intake, possible risk groups 242 13.4 Tolerable upper intake
Load more

Recommended publications
  • Primary Liver Cancer: Epidemiological And
    PRIMARY LIVER CANCER: EPIDEMIOLOGICAL AND BIOMARKER DISCOVERY STUDIES Nimzing Gwamzhi Ladep Imperial College London Department of Medicine December 2013 Thesis submitted for Doctor of Philosophy 1 THESIS ABSTRACT With previous reports indicating changes in mortality, risk factors and management of primary liver cancer (PLC), evaluation of current trends in the incidence and mortality rates was indicated. Late diagnosis has been implicated to be a major contributor to the high fatality rates of PLC. This work aimed at: studying trends of PLC by subcategories globally in general, and in England and Wales, in particular; investigating liver-related morbidities of HIV infected patients in an African setting; and discovering urinary biomarkers of hepatocellular carcinoma. The World Health Organisation (WHO) and Small Area Health Statistics Unit (SAHSU) databases were interrogated respectively, in order to achieve the first aim. The second aim was achieved through utilisation of databases of an African-based HIV treatment programme- AIDS Prevention Initiative in Nigeria (APIN), located in Jos, Nigeria. The European Union-funded Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) case-control study in three West African countries was the platform through which urinary metabolic profiling was accomplished. Proton nuclear magnetic resonance spectroscopy (NMR) and parallel ultra-performance liquid chromatography mass spectrometry (UPLC-MS) were used for biomarker discovery studies. Mortality rates of intrahepatic bile duct carcinoma (IHBD) increased in all countries that were studied. Misclassification of hilar cholangiocarcinoma accounted for only a small increase in the rate of IHBD in England and Wales. With over 90% screening rate for viral hepatitides, the rates of hepatitis B (HBV), hepatitis C (HCV) and 2 HBV/HCV in HIV-infected patients in the APIN programme were 17.8%, 11.3% and 2.5% respectively.
    [Show full text]
  • Preventing Neurological Complications from Dysnatremias in Children
    Pediatr Nephrol (2005) 20:1687–1700 DOI 10.1007/s00467-005-1933-6 REVIEW Michael L. Moritz · J. Carlos Ayus Preventing neurological complications from dysnatremias in children Received: 30 November 2004 / Revised: 28 February 2005 / Accepted: 2 March 2005 / Published online: 4 August 2005 IPNA 2005 Abstract Dysnatremias are among the most common ongoing free-water losses or when mild hypernatremia electrolyte abnormalities encountered in hospitalized pa- (Na>145 mE/l) develops. A group at high-risk for neu- tients. In most cases, a dysnatremia results from improper rological damage from hypernatremia in the outpatient fluid management. Dysnatremias can occasionally result setting is that of the breastfed infant. Breastfed infants in death or permanent neurological damage, a tragic must be monitored closely for insufficient lactation and complication that is usually preventable. In this manu- receive lactation support. Judicious use of infant formula script, we discuss the epidemiology, pathogenesis and supplementation may be called for until problems with prevention and treatment of dysnatremias in children. We lactation can be corrected. report on over 50 patients who have suffered death or neurological injury from hospital-acquired hyponatremia. Keywords Hypernatremia · Hyponatremia · Cerebral The main factor contributing to hyponatremic encepha- edema · Myelinolysis · Fluid therapy lopathy in children is the routine use of hypotonic fluids in patients who have an impaired ability to excrete free- water, due to such causes as the postoperative state, Introduction volume depletion and pulmonary and central nervous system diseases. The appropriate use of 0.9% sodium Dysnatremias are a common electrolyte abnormality in chloride in parenteral fluids would likely prevent most children in both the inpatient and outpatient settings.
    [Show full text]
  • Influence of Marination with Aromatic Herbs and Cold Pressed Oils On
    foods Article Influence of Marination with Aromatic Herbs and Cold Pressed Oils on Black Angus Beef Meat 1 2, 2 2 2 Vasile-Gheorghe Vi¸san , Maria Simona Chi¸s * , Adriana Păucean , Vlad Mures, an , Andreea Pus, cas, , 2 3 4 2 1 Laura Stan , Dan Cristian Vodnar , Francisc Vasile Dulf , Dorin T, ibulcă , Bogdan Alin Vlaic , Iulian Eugen Rusu 2, Csaba Balasz Kadar 2 and Augustin Vlaic 1 1 Department of Fundamental Sciences, Faculty of Animal Science and Biotechnologies Cluj-Napoca, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 3–5 Mănă¸sturStreet, 400372 Cluj-Napoca, Romania; [email protected] (V.-G.V.); [email protected] (B.A.V.); [email protected] (A.V.) 2 Department of Food Engineering, Faculty of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 3–5 Mănă¸sturStreet, 400372 Cluj-Napoca, Romania; [email protected] (A.P.); [email protected] (V.M.); [email protected] (A.P.); [email protected] (L.S.); [email protected] (D.T, .); [email protected] (I.E.R.); [email protected] (C.B.K.) 3 Institute of Life Sciences, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 3–5 Mănăs, tur Street, 400372 Cluj-Napoca, Romania; [email protected] 4 Department of Environmental and Plant Protection, Faculty of Agriculture, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, 3–5 Mănă¸sturStreet, 400372 Cluj-Napoca, Romania; [email protected] Citation: Vi¸san,V.-G.; Chi¸s,M.S.; * Correspondence: [email protected]; Tel.: +40-264-596384 P˘aucean,A.; Mures, an, V.; Pus, cas, , A.; Stan, L.; Vodnar, D.C.; Dulf, F.V.; Abstract: Beef aging is one of the most common methods used for improving its qualities.
    [Show full text]
  • Clinical Aspect of Salt and Water Balance
    Misadventures in salt & water, as well as in acid-base balance Entertaining you is Friedrich C. Luft, Berlin Pflugers Arch 2015 Don’t just “do something” – stand there • 68 year-old woman presents disoriented at 18:00; had undergone tooth extraction that morning and, aside from a life-long mild bleeding tendency, had been quite normal • BP 130/85, pulse regular, respirations 18/min no localizing findings, no edema • Na 118, K 3.6, glucose 8, urea 4 (all mmol/L) • What now? An oil-immersion field showing a normal neutrophil flanked by two giant platelets (Bernard-Soulier syndrome). She had been given desmopressin. In addition, it had been hot so she was advised to “drink lots of water” Serum-Na depends on TBW, Na and K Water in H2 H2O O Na K Serum Na ≈ Naexch + Kexch Total-body H2O Edelman formula Volume Water out Na K Serum Na ≈ Naexch + Kexch total-body H2O Volume Clearance H2O (e) = V 1 - UNa+UK SNa Lots of spheres = little H2O ClH2O(e) neg When UNa+UK >SNa the ClH2O(e) neg and serum Na must fall Few spheres = much H O 2 When UNa+UK < SNa, the Cl (e) pos Cl (e) pos H2O H2O and serum Na must rise Actually, serum Na increased a little faster than we wanted so we infused some free water Had we given 3% saline, serum Na would have increased even faster Iatrogenic SIADH Clin Kidney J 2013;6:96-97 Paradoxal hyponatremia with isotonic electrolyte infusions • 65 year-old woman has meniscus surgery. At that time her Na was 141 mmol/L.
    [Show full text]
  • Secondary Hemochromatosis As a Result of Acute Transfusion-Induced Iron Overload in a Burn Patient Michael Amatto1 and Hernish Acharya2*
    Amatto and Acharya Burns & Trauma (2016) 4:10 DOI 10.1186/s41038-016-0034-z CASE REPORT Open Access Secondary hemochromatosis as a result of acute transfusion-induced iron overload in a burn patient Michael Amatto1 and Hernish Acharya2* Abstract Background: Red blood cell transfusions are critical in burn management. The subsequent iron overload that can occur from this treatment can lead to secondary hemochromatosis with multi-organ damage. Case Presentation: While well recognized in patients receiving chronic transfusions, we present a case outlining the acute development of hemochromatosis secondary to multiple transfusions in a burn patient. Conclusions: Simple screening laboratory measures and treatment options exist which may significantly reduce morbidity; thus, we believe awareness of secondary hemochromatosis in those treating burn patients is critical. Keywords: Secondary hemochromatosis, Transfusion, Iron overload, Burn patients Background of parental iron or RBC transfusions, neonatal iron over- Acute and chronic treatment of the severely burned indi- load, aceruloplasminemia, and African iron overload [6, 7]. vidual is often complex due to many physical and psycho- Hemochromatosis is a disease characterized by iron logical factors [1, 2]. Resuscitation involving packed red accumulation in tissues. Initial symptoms and signs in- blood cell (RBC) transfusion is often essential [3]. How- clude skin pigmentation, fatigue, erectile dysfunction, ever, RBC transfusion carries potential risks including and arthralgia while later stages of the disease result in hemolytic reactions and infections, as well as other com- cardiomyopathy, diabetes mellitus, hypogonadism, hypo- plications that are often overlooked such as iron overload pituitarism, and hypoparathyroidism, as well as liver fi- [4, 5]. Each unit of RBCs contains 200–250 mg of iron, brosis and cirrhosis which can lead to hepatocellular and with no physiologic excretion mechanism, multiple carcinoma [6].
    [Show full text]
  • Orphanet Report Series Rare Diseases Collection
    Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic
    [Show full text]
  • Essential Trace Elements in Human Health: a Physician's View
    Margarita G. Skalnaya, Anatoly V. Skalny ESSENTIAL TRACE ELEMENTS IN HUMAN HEALTH: A PHYSICIAN'S VIEW Reviewers: Philippe Collery, M.D., Ph.D. Ivan V. Radysh, M.D., Ph.D., D.Sc. Tomsk Publishing House of Tomsk State University 2018 2 Essential trace elements in human health UDK 612:577.1 LBC 52.57 S66 Skalnaya Margarita G., Skalny Anatoly V. S66 Essential trace elements in human health: a physician's view. – Tomsk : Publishing House of Tomsk State University, 2018. – 224 p. ISBN 978-5-94621-683-8 Disturbances in trace element homeostasis may result in the development of pathologic states and diseases. The most characteristic patterns of a modern human being are deficiency of essential and excess of toxic trace elements. Such a deficiency frequently occurs due to insufficient trace element content in diets or increased requirements of an organism. All these changes of trace element homeostasis form an individual trace element portrait of a person. Consequently, impaired balance of every trace element should be analyzed in the view of other patterns of trace element portrait. Only personalized approach to diagnosis can meet these requirements and result in successful treatment. Effective management and timely diagnosis of trace element deficiency and toxicity may occur only in the case of adequate assessment of trace element status of every individual based on recent data on trace element metabolism. Therefore, the most recent basic data on participation of essential trace elements in physiological processes, metabolism, routes and volumes of entering to the body, relation to various diseases, medical applications with a special focus on iron (Fe), copper (Cu), manganese (Mn), zinc (Zn), selenium (Se), iodine (I), cobalt (Co), chromium, and molybdenum (Mo) are reviewed.
    [Show full text]
  • Methodologies for Processing Plant Material Into Acceptable Food on a Small Scale- Phase II
    NASAContractorReport177647 Methodologies for Processing Plant Material into Acceptable Food on a Small Scale- Phase II Thomas R. Parks, John N. Bindon, Anthony J. G. Bowles, Peter Golbitz, Rauno A. Lampi, and Robert F. Marquardt Food and AgroSystems, Inc. 1289 Mandarin Dr. Sunnyvale, CA 94087 Prepared for Ames Research Center CONTRACT NAS2-13404 September 1994 National Aeronautics and Space Administration Ames Research Center Moffett Field, California 94035-1000 This report represents the efforts of many, not only principal authors. Food and AgrosSystems sincerely appreciates and wants to acknowledge the valuable contributions made by the following: Mr. Kenneth Carlson Mr. Dan Casper Mr. Fred Coury Dr. Robert Decareau Mr. E. Ray Pariser EXECUTIVE SUMMARY i. Food processing is a technically feasible, effective part of manned space systems. Equipment suitable for processing food on a small scale, under zero-/micro-gravity conditions, have been developed and evaluated on a laboratory prototype scale. 2. Preliminary estimates indicate that while most nutrients can be met by the four crops studied in Phase II, it may be neces- sary to include an additional crop, such as Canola, which has about 2.5 times as much oil content as soy, to aid in meeting dietary fat requirements. 3. Daily planting/harvesting regimens increase personnel invol- vement, but reduce quantities of material to be processed, storage requirements, equipment sizing, energy require- ment (present estimates indicate a possible maximum in- dividual motor peak load of about 2 HP), and opportunities for automation. 4. Use of stable intermediate food products and food processing are compatible with both plant growth and preprepared food systems.
    [Show full text]
  • Genetic Disorder
    Genetic disorder Single gene disorder Prevalence of some single gene disorders[citation needed] A single gene disorder is the result of a single mutated gene. Disorder Prevalence (approximate) There are estimated to be over 4000 human diseases caused Autosomal dominant by single gene defects. Single gene disorders can be passed Familial hypercholesterolemia 1 in 500 on to subsequent generations in several ways. Genomic Polycystic kidney disease 1 in 1250 imprinting and uniparental disomy, however, may affect Hereditary spherocytosis 1 in 5,000 inheritance patterns. The divisions between recessive [2] Marfan syndrome 1 in 4,000 and dominant types are not "hard and fast" although the [3] Huntington disease 1 in 15,000 divisions between autosomal and X-linked types are (since Autosomal recessive the latter types are distinguished purely based on 1 in 625 the chromosomal location of Sickle cell anemia the gene). For example, (African Americans) achondroplasia is typically 1 in 2,000 considered a dominant Cystic fibrosis disorder, but children with two (Caucasians) genes for achondroplasia have a severe skeletal disorder that 1 in 3,000 Tay-Sachs disease achondroplasics could be (American Jews) viewed as carriers of. Sickle- cell anemia is also considered a Phenylketonuria 1 in 12,000 recessive condition, but heterozygous carriers have Mucopolysaccharidoses 1 in 25,000 increased immunity to malaria in early childhood, which could Glycogen storage diseases 1 in 50,000 be described as a related [citation needed] dominant condition. Galactosemia
    [Show full text]
  • Diseases of the Liver and Biliary System
    Diseases of the Liver and Biliary System SHEILA SHERLOCK DBE, FRS MD (Edin.), Hon. DSc (Edin., New York, Yale), Hon. MD (Cambridge, Dublin, Leuven, Lisbon, Mainz, Oslo, Padua, Toronto), Hon. LLD (Aberd.), FRCP, FRCPE, FRACP, Hon. FRCCP, Hon. FRCPI, Hon. FACP Professor of Medicine, Royal Free and University College Medical School University College London, London JAMES DOOLEY BSc, MD, FRCP Reader and Honorary Consultant in Medicine, Royal Free and University College Medical School, University College London, London ELEVENTH EDITION Blackwell Science DISEASES OF THE LIVER AND BILIARY SYSTEM Diseases of the Liver and Biliary System SHEILA SHERLOCK DBE, FRS MD (Edin.), Hon. DSc (Edin., New York, Yale), Hon. MD (Cambridge, Dublin, Leuven, Lisbon, Mainz, Oslo, Padua, Toronto), Hon. LLD (Aberd.), FRCP, FRCPE, FRACP, Hon. FRCCP, Hon. FRCPI, Hon. FACP Professor of Medicine, Royal Free and University College Medical School University College London, London JAMES DOOLEY BSc, MD, FRCP Reader and Honorary Consultant in Medicine, Royal Free and University College Medical School, University College London, London ELEVENTH EDITION Blackwell Science © 1963, 1968, 1975, 1981, 1985, 1989, 1993, 1997, 2002 by Blackwell Science Ltd a Blackwell Publishing Company Editorial Offices: Osney Mead, Oxford OX2 0EL, UK Tel: +44 (0)1865 206206 108 Cowley Road, Oxford OX4 1JF, UK Tel: +44 (0)1865 791100 Blackwell Publishing USA, 350 Main Street, Malden, MA 02148-5018, USA Tel: +1 781 388 8250 Iowa State Press, a Blackwell Publishing Company, 2121 State Avenue, Ames,
    [Show full text]
  • Inhibition of Enzymatic Browning in Foods and Beverages
    Critical Reviews in Food Science and Nutrition ISSN: 1040-8398 (Print) 1549-7852 (Online) Journal homepage: http://www.tandfonline.com/loi/bfsn20 Inhibition of enzymatic browning in foods and beverages Arthur J. McEvily , Radha Iyengar & W. Steven Otwell To cite this article: Arthur J. McEvily , Radha Iyengar & W. Steven Otwell (1992) Inhibition of enzymatic browning in foods and beverages, Critical Reviews in Food Science and Nutrition, 32:3, 253-273, DOI: 10.1080/10408399209527599 To link to this article: https://doi.org/10.1080/10408399209527599 Published online: 29 Sep 2009. Submit your article to this journal Article views: 848 View related articles Citing articles: 254 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=bfsn20 Download by: [Texas A&M University Libraries] Date: 09 January 2018, At: 11:03 Critical Reviews in Food Science and Nutrition, 32(3):253-273 (1992) Inhibition of Enzymatic Browning in Foods and Beverages Arthur J. McEvily and Radha lyengar Opta Food Ingredients, Inc., 64 Sidney Street, Cambridge, MA 02139 W. Steven Otwell Department of Food Science and Human Nutrition, University of Florida, Gainesville, FL 32611 ABSTRACT: Enzymatic browning is a major factor contributing to quality loss in foods and beverages. Sulfiting agents are used commonly to control browning; however, several negative attributes associated with sulfites have created the need for functional alternatives. Recent advances in the development of nonsulfite inhibitors of enzymatic browning are reviewed. The review fouses on compositions that are of practical relevance to food use. KEY WORDS: enzymatic browning, polyphenol oxidase, inhibition, antibrowning agents, melanosis.
    [Show full text]
  • Chemical Compound Chemical Treatment in Animal Husbandry
    Hindawi Journal of Chemistry Volume 2020, Article ID 4263124, 8 pages https://doi.org/10.1155/2020/4263124 Research Article Chemical Compound Chemical Treatment in Animal Husbandry Xiaoling Tang 1 and Ting Peng2 1Hunan Vocational College of Environmental Biological Technology, Hengyang 421005, Hunan, China 2Department of Chemistry, Zhejiang Xianju High School, Taizhou 317300, Zhejiang, China Correspondence should be addressed to Xiaoling Tang; [email protected] Received 6 August 2020; Revised 9 September 2020; Accepted 21 September 2020; Published 20 November 2020 Academic Editor: Tifeng Jiao Copyright © 2020 Xiaoling Tang and Ting Peng. )is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. )e acidulant is widely used in the production of animal husbandry, and its use is affected by many factors, including envi- ronmental factors, dosage, diet composition, and animal’s own factors, so only the correct use of the acidulant can bring good results in animal production and financial income. )is article takes acidifier as an example to study the application of compound chemical treatment in livestock farms. In this paper, the effect of using acidulant in the first 1 to 3 weeks after early weaning of piglets is obvious through this experimental study. )e effect gradually decreases after 3 weeks and basically has no effect after 4 weeks. Experimental studies have found that the combination of organic acids, antibiotics, and high copper is the most effective. )ese three have different functions and have complementary or additive effects.
    [Show full text]